© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filing Details
Document Details
Form
Filing Date
Jun 22, 2021
Document Date
Jun 21, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intra-Cellular Therapies Inc.
Issuer
INTRA-CELLULAR THERAPIES, INC.
Filer
Rawlins Michael